Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 215

1.

Cerebral 5-HT release correlates with [11C]Cimbi36 PET measures of 5-HT2A receptor occupancy in the pig brain.

Jørgensen LM, Weikop P, Villadsen J, Visnapuu T, Ettrup A, Hansen HD, Baandrup AO, Andersen FL, Bjarkam CR, Thomsen C, Jespersen B, Knudsen GM.

J Cereb Blood Flow Metab. 2017 Feb;37(2):425-434. doi: 10.1177/0271678X16629483. Epub 2016 Jul 20.

PMID:
26825776
2.

Distinct Circuits Underlie the Effects of 5-HT1B Receptors on Aggression and Impulsivity.

Nautiyal KM, Tanaka KF, Barr MM, Tritschler L, Le Dantec Y, David DJ, Gardier AM, Blanco C, Hen R, Ahmari SE.

Neuron. 2015 May 6;86(3):813-26. doi: 10.1016/j.neuron.2015.03.041. Epub 2015 Apr 16.

3.

Is pindolol augmentation effective in depressed patients resistant to selective serotonin reuptake inhibitors? A systematic review and meta-analysis.

Liu Y, Zhou X, Zhu D, Chen J, Qin B, Zhang Y, Wang X, Yang D, Meng H, Luo Q, Xie P.

Hum Psychopharmacol. 2015 May;30(3):132-42. doi: 10.1002/hup.2465. Epub 2015 Feb 17. Review.

PMID:
25689398
4.

[Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].

Ammar G, Naja WJ, Pelissolo A.

Encephale. 2015 Jun;41(3):260-5. doi: 10.1016/j.encep.2013.11.002. Epub 2014 Nov 14. Review. French.

PMID:
25439852
5.

Obsessive-compulsive disorder.

Bokor G, Anderson PD.

J Pharm Pract. 2014 Apr;27(2):116-30. doi: 10.1177/0897190014521996. Epub 2014 Feb 27. Review.

PMID:
24576790
6.

5-HT1B receptor modulation of the serotonin transporter in vivo: studies using KO mice.

Montañez S, Munn JL, Owens WA, Horton RE, Daws LC.

Neurochem Int. 2014 Jul;73:127-31. doi: 10.1016/j.neuint.2013.11.004. Epub 2013 Nov 15.

7.

Structural basis for molecular recognition at serotonin receptors.

Wang C, Jiang Y, Ma J, Wu H, Wacker D, Katritch V, Han GW, Liu W, Huang XP, Vardy E, McCorvy JD, Gao X, Zhou XE, Melcher K, Zhang C, Bai F, Yang H, Yang L, Jiang H, Roth BL, Cherezov V, Stevens RC, Xu HE.

Science. 2013 May 3;340(6132):610-4. doi: 10.1126/science.1232807. Epub 2013 Mar 21.

8.

A short-term double-blind randomized controlled pilot trial with active or placebo pindolol in patients treated with venlafaxine for major depression.

Martiny K, Lunde M, Bech P, Plenge P.

Nord J Psychiatry. 2012 Jun;66(3):147-54. doi: 10.3109/08039488.2012.674553. Epub 2012 Mar 29.

PMID:
22458638
9.

Can pindolol really enhance antidepressant effect?

Terao T.

J Clin Psychiatry. 2011 Nov;72(11):1558; author reply 1558. doi: 10.4088/JCP.11lr07366. No abstract available.

PMID:
22127196
10.

The antidepressant-like effect of Hedyosmum brasiliense and its sesquiterpene lactone, podoandin in mice: evidence for the involvement of adrenergic, dopaminergic and serotonergic systems.

Gonçalves AE, Bürger C, Amoah SK, Tolardo R, Biavatti MW, de Souza MM.

Eur J Pharmacol. 2012 Jan 15;674(2-3):307-14. doi: 10.1016/j.ejphar.2011.11.009. Epub 2011 Nov 12.

11.

Preclinical and clinical characterization of the selective 5-HT(1A) receptor antagonist DU-125530 for antidepressant treatment.

Scorza MC, Lladó-Pelfort L, Oller S, Cortés R, Puigdemont D, Portella MJ, Pérez-Egea R, Alvarez E, Celada P, Pérez V, Artigas F.

Br J Pharmacol. 2012 Nov;167(5):1021-34. doi: 10.1111/j.1476-5381.2011.01770.x.

12.

Essential role for orbitofrontal serotonin 1B receptors in obsessive-compulsive disorder-like behavior and serotonin reuptake inhibitor response in mice.

Shanahan NA, Velez LP, Masten VL, Dulawa SC.

Biol Psychiatry. 2011 Dec 1;70(11):1039-48. doi: 10.1016/j.biopsych.2011.07.032. Epub 2011 Sep 13.

13.

Serotonin-1A receptors in the dorsal periaqueductal gray matter mediate the panicolytic-like effect of pindolol and paroxetine combination in the elevated T-maze.

Sela VR, Biesdorf C, Ramos DH, Zangrossi H Jr, Graeff FG, Audi EA.

Neurosci Lett. 2011 May 9;495(1):63-6. doi: 10.1016/j.neulet.2011.03.040. Epub 2011 Mar 21.

14.

Can we really accelerate and enhance the selective serotonin reuptake inhibitor antidepressant effect? A randomized clinical trial and a meta-analysis of pindolol in nonresistant depression.

Portella MJ, de Diego-Adeliño J, Ballesteros J, Puigdemont D, Oller S, Santos B, Álvarez E, Artigas F, Pérez V.

J Clin Psychiatry. 2011 Jul;72(7):962-9. doi: 10.4088/JCP.09m05827blu. Epub 2010 Oct 19.

PMID:
21034693
16.

Pindolol potentiates the panicolytic effect of paroxetine in the elevated T-maze.

Sela VR, Roncon CM, Zangrossi H Jr, Graeff FG, Audi EA.

Life Sci. 2010 Sep 25;87(13-14):445-50. doi: 10.1016/j.lfs.2010.08.009. Epub 2010 Sep 9.

PMID:
20816996
17.

Pindolol augmentation enhances response outcomes in first depressive episodes.

Portella MJ, de Diego-Adeliño J, Puigdemont D, Pérez-Egea R, Alvarez E, Artigas F, Pérez V.

Eur Neuropsychopharmacol. 2009 Jul;19(7):516-9. doi: 10.1016/j.euroneuro.2009.04.004. Epub 2009 May 5.

PMID:
19419845
18.

A short duration of untreated illness (DUI) improves response outcomes in first-depressive episodes.

de Diego-Adeliño J, Portella MJ, Puigdemont D, Pérez-Egea R, Alvarez E, Pérez V.

J Affect Disord. 2010 Jan;120(1-3):221-5. doi: 10.1016/j.jad.2009.03.012.

PMID:
19349077
19.

beta(2)-adrenoceptors are critical for antidepressant treatment of neuropathic pain.

Yalcin I, Choucair-Jaafar N, Benbouzid M, Tessier LH, Muller A, Hein L, Freund-Mercier MJ, Barrot M.

Ann Neurol. 2009 Feb;65(2):218-25. doi: 10.1002/ana.21542.

PMID:
19259968
20.

Acute effects of combining citalopram and pindolol on regional brain serotonin synthesis in sham operated and olfactory bulbectomized rats.

Nguyen KQ, Tohyama Y, Watanabe A, Hasegawa S, Skelin I, Diksic M.

Neurochem Int. 2009 Mar-Apr;54(3-4):161-71. doi: 10.1016/j.neuint.2008.08.012. Epub 2008 Nov 27.

Supplemental Content

Loading ...
Support Center